Assisted Reproductive Technology Market Set to Reach USD 80.5 Billion by 2034

Assisted Reproductive Technology Market The global assisted reproductive technology (ART) market is witnessing unprecedented growth, reflecting both rising infertility rates and technological breakthroughs. The market was valued at USD 31.6 billion in 2025 and is projected to expand to USD 80.5 billion by 2034 , growing at a CAGR of 10.95% (2026–2034) . Key factors driving this growth include delayed parenthood, changing lifestyles, obesity, PCOS, and hormonal disruptions. ART procedures primarily in-vitro fertilization (IVF), artificial insemination, embryo screening, and fertility preservation are increasingly sought as individuals and couples pursue reliable solutions for parenthood. In 2024, the U.S. Society for Assisted Reproductive Technology (SART) reported 95,860 babies born via IVF, accounting for 2.6% of total U.S. births, highlighting ART’s growing mainstream adoption. Market Opportunities AI and Automation – Artificial intelligence is transforming embryo selection,...